Tandem Diabetes Care is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO John F. Sheridan, with a market cap of $1.4B.
Common questions about Tandem Diabetes Care
Tandem Diabetes Care is scheduled to report earnings for Q1 2026 on May 7, 2026 after market close. Analysts estimate revenue of $240.4M.
Tandem Diabetes Care has approximately 2,400 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.